Oncolytics at Fresh 52-Week High on Drug Results
Oncolytics Biotech Inc. (T.ONC) hit a new 52-week high of $2.50 Thursday. Oncolytics announced updated results from the phase 1/2 GOBLET study's first-line advanced/metastatic pancreatic ductal adenocarcinoma (PDAC) cohort. Patients in this cohort are treated with the combination of pelareorep, Roche's anti-PD-L1 checkpoint inhibitor atezolizumab, and the chemotherapeutic agents gemcitabine and nab-paclitaxel.
Alamos Gold Inc. (T.AGI) hit a new 52-week high of $11.85 Thursday. No news stories available today.
Alimentation Couche-Tard Inc. (T.ATD) hit a new 52-week high of $62.38 Thursday. No news stories available today.
CES Energy Solutions Corp. (T.CEU) hit a new 52-week high of $3.17 Thursday. No news stories available today.
Enterprise Group Inc. (T.E) hit a new 52-week high of 41.5 cents Thursday. No news stories available today.
Metro Inc. (T.MRU) hit a new 52-week high of $73.29 Thursday. No news stories available today.
Pet Valu Holdings Ltd. (T.PET) hit a new 52-week high of $41.74 Thursday. No news stories available today.
Read:
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
New Biotech Sector Drug Combinations Target a Drop in Pancreatic Cancer Mortality Rates
Highly Sought After Natural Ingredients Appearing in More Plant-Based Products Across North America
Fresher, Healthier Food Options Coming Soon to an Airplane Tray Near You
Airline Industry Wooing Back Customers with Enhanced, Healthier Menu Options
Shawcor Ltd. (T.SCL) hit a new 52-week high of $10.10 Thursday. No news stories available today.
Stella-Jones Inc. (T.SJ) hit a new 52-week high of $44.37 Thursday.
Uni-Select Inc. (T.UNS) hit a new 52-week high of $41.74 Thursday. No news stories available today.